The transport and accumulation of phytohemagglutinin in developing bean (Phaseolus vulgaris L.) cotyledons is accompanied by the transient presence of N-acetylglucosamine (GIcNAc) residues on the oligosaccharide sidechains of this glycoprotein. These peripheral GlcNAc residues can be distinguished from those in the chitobiose portion of the oligosaccharide sidechains by their sensitivity to removal by the exoglycosidase fl-N-acetylglucosaminidase. GlcNAc residues sensitive to removal by 0-N-acetylglucosaminidase are present not only on phytohemagglutinin, but also on other newly synthesized proteins. The enzyme UDPGIcNAc:glycoprotein GlcNAc-transferase which transfers GIcNAc residues to glycoproteins was first described by Davies and Delmer (Plant Physiol 1981 68: 284-291). The data presented here show that this enzyme is associated with the Golgi complex of developing cotyledons.
We recently observed ( 13) that the transport of PHA2 from its site of synthesis (the rough ER) to its site of accumulation (the protein-storage vacuoles or protein bodies) during the development of bean seeds is accompanied by the addition of terminal N-acetylglucosamine GlcNAc residues in the Golgi complex, and by their subsequent removal in the protein bodies. The GlcNAc residues are added to the modified oligosaccharide sidechains of PHA, which at maturity have GlcNAc, Man, Fuc, and Xyl in the molar ratios of 2:3.8:0.6:0.5 (14) . This observation prompted us to find out if other glycoproteins have terminal GlcNAc residues, and to localize the GlcNAc transferase responsible for the addition of GlcNAc residues to glycoprotein. Considerable work has been done on the UDP-GlcNAc:glycoprotein GlcNActransferases of animal cells, and at least four different enzymes with different specificities have been identified (6 Digestion of Glycoproteins and Analysis of Glycopeptides. Glycoproteins were digested with proteinases as described (14) and the resulting glycopeptides purified and digested further with fl-N-acetylglucosaminidase (Sigma) . Conditions for these digestions and for the analysis of the resulting products on Biogel P4 (Bio-Rad) columns have been described (12, 14) .
Analysis of Radioactive Polypeptides. Radioactive polypeptides were analyzed by SDS-PAGE as described (8) (Table I) show that a considerable proportion of the GlcNAc was in a terminal position. In a short-term labeling experiment, the proportion of terminal GlcNAc was much higher in the soluble than in the organelle fraction, and the proportion of terminal GIcNAc decreased in the soluble fraction with time oflabeling. In a second experiment, the homogenate was not fractionated into soluble and membranous organelles as in Table I , but was prepared in the presence of 1% Tween 20, so that all the membranes dissolved. Phytohemagglutinin was removed by affinity chromatography with thyroglobulin-Sepharose (4) , and the remaining glycoproteins examined. Glycopeptides were isolated and treated with f3-N-acetylglucosaminidase to determine the proportion of radioactivity in terminal GlcNAc residues. The proportion of radioactivity which was released by fl-N-acetylglucosaminidase was 22.6% after 2.5 h of labeling and 9.1% after 22 h of labeling. Together, these results show that the presence of terminal GlcNAc residues is a feature of glycoproteins in general, and is not restricted to PHA.
In Vitro Transfer of GlcNAc from UDP-GlcNAc to Glycoproteins. Our experiments on the transport and processing of PHA (13) showed that terminal GlcNAc residues were added in the Golgi apparatus and removed again in the protein bodies, indicating that the Golgi apparatus may have a UDPGlcNAc:glycoprotein GlcNAc-transferase. The activity of such an enzyme in the total organelle fraction of developing cotyledons was assayed using a simplified version of the method developed by Davies and Delmer (2) . Aliquots of the organelle MnCI2, and the incorporation of radioactivity into glycoproteins measured. The kinetics of incorporation showed that there was little additional transfer of GlcNAc after 30 min of incubation (data not shown). The presence ofnonradioactive GDP-mannose during the incubation and a chase with nonradioactive UDPGlcNAc, as described by Davies and Delmer (3), did not enhance the incorporation, and were therefore omitted. The radioactive proteins were analyzed by SDS-PAGE and fluorography (Fig. 1, lane A) and compared with the radioactive proteins present in an organelle fraction of cotyledons labeled in vivo with [3H]GlcN for 2 h (Fig. 1, lane B) . Most of the radioactivity was in the polypeptides of phaseolin and PHA, whether the organelle fraction was labeled in vitro with UDP-GlcNAc, or the cotyledons were labeled in vivo with GlcNAc. That the in vitro incorporation was mostly in PHA and phaseolin was confirmed by immunoaffinity chromatography using antibodies to PHA and phaseolin (data not shown) as was demonstrated by Davies and Delmer (3) . It is obvious from Figure 1 that there is differential labeling of the individual polypeptides. For example, the smallest polypeptide of phaseolin has relatively much more GlcNAc in vitro than in vivo (arrow). Localization of the Enzyme on Sucrose Gradients. Homogenates ofcotyledons were chromatographed on Sepharose 4B to separate the organelles from the soluble molecules, and the organelles were subjected to fractionation on isopycnic linear sucrose gradients. The fractions were assayed for NADH-Cyt c reductase (an enzyme marker for the ER), inosinediphosphatase (an enzyme marker for the Golgi), and UDP-GlcNAc:glycoprotein GlcNAc-transferase activity. Homogenization, chromatography on Sepharose 4B, and sucrose gradient centrifugation were carried out in media which contained 1 organelles have the same density whether EDTA or MgCl2 is present. The results (Fig. 2) show that GlcNAc-transferase banded at a density of 1.13 g cm-3 whether EDTA or MgCI2 was present in the medium, and the enzyme banded in the same position as inosinediphosphatase, a Golgi marker enzyme. NADH-Cyt c reductase, indicated by a horizontal bar in Figure  2 , banded at 1.13 g cm3 in the presence of EDTA, and at 1.18 g.cm-3 in the presence of MgC12. (5) .
The presence of terminal GlcNAc residues on glycoproteins appears not to be limited to PHA (Table I) (7) . In vitro, both PHA and phaseolin are glycosylated with GlcNAc. Since phaseolin has high-mannose oligosaccharide sidechains (MangGlcNAc2), the enzyme(s) would appear to transfer GlcNAc residues to such high-mannose groups, at least in vitro. This is definitely not the case in animal cells where in vivo transfer occurs only to oligosacharide sidechains which have lost at least four mannose residues (6) . The possibility that the in vitro transfer of GlcNAc residues occurs to partially degraded highmannose chains on phaseolin cannot be excluded. Indeed, membrane preparations always contain a-mannosidase activity (12). However, inclusion of swainsonine, an inhibitor of a-mannosidase, in the incubation mixture did not inhibit the incorporation ofGlcNAc into the protein (data not shown). A second possibility is that most of the oligosaccharide sidechains of phaseolin are of the high-mannose type, while a minority have fewer mannose residues (e.g. GlcNAc2Man5), and that it is to these shorter chains that GIcNAc is transferred.
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